Biomarker for Gilbert Disease (BioGilbert)
NCT02712138 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-02-13
Summary
Development of a new MS-based biomarker for the early and sensitive diagnosis of Gilbert disease from blood
Conditions
- Meulengracht Syndrome
- Hyperbilirubinemia
- Unconjugated Benign Bilirubinemia
Sponsors & Collaborators
-
CENTOGENE GmbH Rostock
lead INDUSTRY
Principal Investigators
-
Peter Bauer, Prof. · Centogene GmbH
Eligibility
- Min Age
- 2 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-20
- Primary Completion
- 2021-02-28
- Completion
- 2021-02-28
Countries
- Egypt
- India
- Sri Lanka
Study Locations
More Related Trials
-
B7 Coreceptor Molecules in Hyper IgD Syndrome Form of Mevalonate Kinase Deficiency
NCT01568736 ·Status: WITHDRAWN
-
Calprotectin and Ischemia Modified Albumin Serum to Measure Disease Activity in Behçet's Disease
NCT05868538 ·Status: COMPLETED
-
Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD)
NCT05915897 ·Status: TERMINATED
-
Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients
NCT01672164 ·Status: COMPLETED
-
New Biomarkers for Diagnosis and Follow-up of Patients With LRBA or CTLA4 Deficiencies
NCT04377867 ·Status: UNKNOWN
-
Cytokines and the Risk of Infection in Liver Cirrhosis
NCT00857181 ·Status: TERMINATED
-
Prevalence of Circulating Parvovirus Genome in Recently Diagnosed Graves' Disease: a Case-control Study
NCT02798965 ·Status: COMPLETED ·Phase: NA
-
ST-2; a Non-invasive Fibrosis Marker for Chronic Hepatitis B
NCT01633554 ·Status: UNKNOWN
-
Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related Disease
NCT02899039 ·Status: COMPLETED ·Phase: NA
-
Cell Bound Complement Activation Proteins as Markers of Liver Injury
NCT01025531 ·Status: WITHDRAWN
-
Investigation of the Validity, Reliability and Responsiveness of the BETY-BQ in FMF
NCT06830213 ·Status: NOT_YET_RECRUITING
-
Autoimmune Hepatitis Study
NCT00286663 ·Status: TERMINATED
-
Single Cell Landscape of HBV-related Acute-on-chronic Liver Failure Patients
NCT06865859 ·Status: RECRUITING
-
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
NCT00160940 ·Status: UNKNOWN
-
Bartonella in Liver Transplant Patients
NCT02595710 ·Status: COMPLETED
-
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
NCT07146906 ·Status: RECRUITING ·Phase: PHASE2
-
sgp130 in Chronic Human Liver Disease
NCT00770198 ·Status: COMPLETED
-
Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects
NCT00762801 ·Status: WITHDRAWN
-
Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia
NCT00169871 ·Status: COMPLETED
-
The Microbiome Composition in Women With Recurring Intrahepatic Cholestasis of Pregnancy (ICP)
NCT05151913 ·Status: COMPLETED
-
Study of Copeptin as a Diagnostic Marker for Acute Pancreatitis
NCT01293318 ·Status: COMPLETED
-
Il-17 Levels in Intrahepatic Cholestasis of Pregnancy
NCT01898832 ·Status: UNKNOWN
-
Investigation of the Influence of the Human Microbiome on Giant Cell Arteritis
NCT06279065 ·Status: RECRUITING
-
Serum Regucalcin Level and Chronic Hepatitis B
NCT05435599 ·Status: COMPLETED ·Phase: NA
-
Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis
NCT02616705 ·Status: COMPLETED